Medtronic Cardiac Surgery
Clinical trials sponsored by Medtronic Cardiac Surgery, explained in plain language.
-
Heart surgery breakthrough? new ablation device targets stubborn AFib
Disease control Recruiting nowThis study tests if using a special energy device (radiofrequency ablation) during planned open-heart surgery can safely stop long-lasting atrial fibrillation (AFib). About 160 people with persistent AFib who need heart surgery for other reasons will take part. The goal is to see…
Phase: NA • Sponsor: Medtronic Cardiac Surgery • Aim: Disease control
Last updated May 22, 2026 14:03 UTC
-
5,000-Patient heart device registry launches to monitor Real-World safety
Knowledge-focused Recruiting nowThis study is a large registry that will follow 5,000 people who receive Medtronic heart devices. Its goal is to confirm the devices are safe and work well in everyday use, and to spot any new risks. No experimental treatment is given—just careful observation of routine care.
Sponsor: Medtronic Cardiac Surgery • Aim: Knowledge-focused
Last updated May 26, 2026 08:57 UTC
-
Heart valve registry tracks device safety in thousands
Knowledge-focused Recruiting nowThis study is a registry that will follow up to 2,700 people who have received or will receive a Medtronic heart valve product during surgery. The goal is to monitor the long-term safety and performance of these devices by identifying any unexpected problems or trends. Participan…
Sponsor: Medtronic Cardiac Surgery • Aim: Knowledge-focused
Last updated May 22, 2026 14:03 UTC